Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betamethasone valerate 0.1% oint 50% in Gen Unguentum M crm
1304000F0AAFSFS
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 4 |
|
Betnovate-C cream
1304000F0BBAKCA
|
Betnovate (Topical) | Betamethasone valerate | Skin | 4 |
|
Cholesterol 2% / Simvastatin 2% cream
1305020Z0AAAAAA
|
Cholesterol/simvastatin | Cholesterol/simvastatin | Skin | 4 |
|
Clobetasol 0.05% oint 25%/Coal tar soln 5% in WSP
1304000H0AACLCL
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | 4 |
|
Coal tar 5% in Betamethasone valerate 0.025% ointment
1304000F0AAEKEK
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 4 |
|
Coal tar solution strong 2.5% in Emulsifying ointment
1305020C0AAFJFJ
|
Coal tar/tar (Topical) | Tars | Skin | 4 |
|
Dioderm 0.1% cream
1304000V0BBAAAW
|
Dioderm | Hydrocortisone | Skin | 4 |
|
Emcrem cream
130201000BBMBDL
|
Proprietary compound emollients | Other emollient preparations | Skin | 4 |
|
Glycopyrronium bromide 0.1% topical solution
1312000G0AAAFAF
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 4 |
|
Glycopyrronium bromide 1% cream
1312000G0AAAMAM
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 4 |
|
Industrial methylated spirit 70%
1311010A0AAADAD
|
Industrial methylated spirit | Alcohol | Skin | 4 |
|
Larvae sterile
1311070S0AAAAAA
|
Ster larvae | Ster larvae | Skin | 4 |
|
Reflectant sunscreen coral pink (Dundee formula) cream
1308010U0AAALAL
|
Titanium dioxide (Sunscreen) | Titanium dioxide | Skin | 4 |
|
Salicylic acid 3% / Lactic acid 3% in White soft paraffin
1307000M0AABTBT
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 4 |
|
Sodium chloride 0.9% solution
1311010S0AAADAD
|
Sod chlor (Topical) | Sodium chloride | Skin | 4 |
|
Stelara 45mg/0.5ml inj pre-filled syringes
1305030D0BBABAB
|
Stelara | Ustekinumab | Skin | 4 |
|
Sterets H Pre-injection swab
1311010I0BGAAAF
|
Sterets H | Isopropyl alcohol | Skin | 4 |
|
Toctino 30mg capsules
1305010AFBBABAB
|
Toctino | Alitretinoin | Skin | 4 |
|
Tretinoin 0.05% gel
1306010V0AAAKAK
|
Tretinoin (Acne) | Tretinoin | Skin | 4 |
|
Vitamin E 50units/g cream
1302010W0AAADAD
|
Vitamin E (Topical) | Vitamin E | Skin | 4 |
|
Viticolor gel
130802000BBEDA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 4 |
|
Zorac 0.05% gel
1305020T0BBAAAA
|
Zorac | Tazarotene | Skin | 4 |
|
Ambre Solaire UV Sensitive protection milk SPF 50+
130801000BBNXA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 3 |
|
Anthisan 2% cream
1303000M0BBAAAA
|
Anthisan (Topical) | Mepyramine maleate | Skin | 3 |
|
Antipeol ointment
131005000BBADAD
|
Proprietary compound preparation BNF 1310050 | Other minor cut and abrasion preparations | Skin | 3 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.